We determined that the brain metastases, carcinoma, and stromal areas, contained fewer immune cells than the paired primary lung cancer, except for CD204-positive (CD204+) cells, which were higher in the carcinoma areas of the brain metastases. This evidence concerns the gene MSR1 and lung carcinoma.